Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Crataegus gracilior, commonly known as Mexican hawthorn or tejocote, is a plant species native to Mexico whose extracts are traditionally used in Mexican folk medicine. Research has demonstrated that petroleum ether extracts of its leaves and stems possess cytotoxic and pro-apoptotic activities against breast cancer cells, which are attributed to bioactive compounds such as β-sitosterol and tocopherol. Additionally, methanol and aqueous extracts of its leaves, fruits, and flowers have shown vasorelaxant and cardioprotective properties, suggesting potential therapeutic utility in cardiovascular diseases like hypertension.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Crataegus gracilior.